Novità da Vivetus®
Adults 40+: What 8–12 Weeks of Oral Quercetin M...
Evidence led guide for adults 40+. Learn what human trials do and do not show about oral quercetin for skin, why formulation and dose change absorption,...
Adults 40+: What 8–12 Weeks of Oral Quercetin M...
Evidence led guide for adults 40+. Learn what human trials do and do not show about oral quercetin for skin, why formulation and dose change absorption,...
Raise Blood NAD+ in 4–8 Weeks with NMN: Trial E...
Evidence first: NMN raises blood NAD+ in 4 to 8 weeks; resveratrol shows metabolic benefits. Trial based dosing, safety notes, and Vivetus product options.
Raise Blood NAD+ in 4–8 Weeks with NMN: Trial E...
Evidence first: NMN raises blood NAD+ in 4 to 8 weeks; resveratrol shows metabolic benefits. Trial based dosing, safety notes, and Vivetus product options.
15× higher quercetin exposure: Dutch take on br...
Balanced, Netherlands-aware review of quercetin and bromelain: what human trials show for allergy and recovery, how formulation can boost quercetin up to...
15× higher quercetin exposure: Dutch take on br...
Balanced, Netherlands-aware review of quercetin and bromelain: what human trials show for allergy and recovery, how formulation can boost quercetin up to...
500 mg With Dinner: Safer Berberine Use Before ...
For readers in the Netherlands: take berberine before bed only with dinner. Prefer 500 mg as part of a 1,000–1,500 mg per day split, and check drug...
500 mg With Dinner: Safer Berberine Use Before ...
For readers in the Netherlands: take berberine before bed only with dinner. Prefer 500 mg as part of a 1,000–1,500 mg per day split, and check drug...
Resveratrol and Quercetin: 68% Cut in Lipid Dam...
Review the trial behind a 68% fall in exercise lipid damage and learn why absorption and CYP drug interactions decide whether resveratrol plus quercetin...
Resveratrol and Quercetin: 68% Cut in Lipid Dam...
Review the trial behind a 68% fall in exercise lipid damage and learn why absorption and CYP drug interactions decide whether resveratrol plus quercetin...
40% Drug Rise in Trial: Berberine Interactions ...
A two week trial found berberine raised a CYP3A4 marker about 40% and reduced CYP2D6. See which medicines are risky and what monitoring helps.
40% Drug Rise in Trial: Berberine Interactions ...
A two week trial found berberine raised a CYP3A4 marker about 40% and reduced CYP2D6. See which medicines are risky and what monitoring helps.